Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Comment by Bigboyoneon Nov 09, 2016 5:09pm
176 Views
Post# 25442310

RE:RE:Woo!

RE:RE:Woo!Canadians just dont understand how big this is being that OBAMACARE may be scrapped..With Socialized medicine, its a gift.
We in The US (Working class) went from example my monthly premium from $200 a month to over $700 a month. In theory the working class was supposed to pay in, but a large % where not.
The Free lunch people (LARGE % OBAMA CARE) think that the govmt pays for the Healthcare, it does not, the people who pay in, are paying forthose who dont., I would rathe rpay a large premium on meds, then monthly of a my Healthcare that I am not really using..

Back to ARALEZ, the BIOMED index today had its largest GAP UP ever..Last week, we where ,04 away from a 52 week low..Now we are close to 40 above the low..amazing..

After litening to the CC, 
Here is my rough Esitmate for 2017
Toprol 80-90 Mil
Yosprala $25-$30 Mil
Vimovo $15-20 Mil
Fibricor $4-$6mil
Zontiv$$-$6 mil
Expect also Tribute little group of Canadian Drugs..
$30Mil-Maybe $40
Revenue =$160-200Mil

At this time it is obvious Yoprala is the main engine and I can see with Japan and the EU,(Submission shortly to EU) in 4-5 yrs @ $250Mil
Add this to growth and another $250Mil Estimated in 4-5 yrs USA sales.
We have crazy numbers, and based on P/E $35 -$40 is realistic, but I am sure we will be bought out well before that, probably at $20 or so.. 
Back to Trump- this is now a realistic reality, and we may be sitting on a little goldmine just waiting to explode.

<< Previous
Bullboard Posts
Next >>